[Second-generation long-acting injectable antipsychotics in clinical practice].

Abstract

On the example of 5 clinical cases of paranoid schizophrenia at different stages of the development of the disease, the therapeutic tactics of using drugs from the group of second-generation injectable prolong antipsychotics to solve problems that arise during anti-relapse therapy are shown. The research data substantiating these approaches are presented. Various combination therapy options are discussed, including at the stage of drug replacement and the appointment of a second-generation long-acting injectable antipsychotic.

• Authors: N N Petrova, E V Grigorieva
• Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (Zh Nevrol Psikhiatr Im S S Korsakova) Vol. 122 Issue 2 Pg. 115-123 ( 2022) ISSN: 1997-7298 [Print] Russia (Federation)
• Vernacular Title: In"ektsionnye antipsikhotiki-prolongi vtoroi generatsii v klinicheskoi praktike.
• PMID: 35271246 (Publication Type: Journal Article)

Chemical References

• Antipsychotic Agents
• Delayed-Action Preparations

Topics

• Antipsychotic Agents (therapeutic use)
• Delayed-Action Preparations
• Humans
• Injections
• Recurrence
• Schizophrenia, Paranoid (drug therapy)